Background A major determinant of treatment offered to patients with non‐small cell lung
cancer (NSCLC) is their intrathoracic (mediastinal) nodal status. If the disease has not …

Visualization of the lymphatic system is clinically necessary during diagnosis or treatment of
many conditions and diseases; it is used for identifying and monitoring lymphedema, for …

Purpose This study aimed to explore the clinical staging performance of [68 Ga] Ga-DOTA-
FAPI-04 PET/CT compared with that of 2-[18F] FDG PET/CT in non-small cell lung cancer …

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) can
reliably sample enlarged mediastinal lymph nodes in patients with non-small cell lung …

Rationale: Early discovery, accurate diagnosis, and staging of lung cancer is essential for
patients to receive appropriate treatment. PET/CT has become increasingly recognized as a …

Introduction Accurate clinical staging of mediastinal lymph nodes (MLNs) of patients with
non-small cell lung cancer (NSCLC) is important in determining therapeutic options and …

Ultrasound imaging has gained importance in pulmonary medicine over the last decades
including conventional transcutaneous ultrasound (TUS), endoscopic ultrasound (EUS), and …

Purpose: We conducted genome-wide miRNA-sequencing (miRNA-seq) in primary cancer
tissue from patients of lung adenocarcinoma to identify markers for the presence of lymph …

The integral role of positron-emission tomography (PET) using the glucose analog tracer
fluorine-18 fluorodeoxyglucose (FDG) in the staging of non-small cell lung cancer (NSCLC) …

Objective: We sought to assess the clinical implication and prognostic significance of
maximum standardised uptake value (SUVmax) of primary non-small cell lung cancer …